Pfizer Reports Positive Phase 3 Results for LITFULO in Nonsegmental Vitiligo Pfizer Inc. (NYSE: PFE) has announced detailed results from two Phase 3 clinical trials evaluating LITFULO® (ritlecitinib) as a…
Travere to Present New FILSPARI Data in IgA Nephropathy and FSGS at ASN Kidney Week 2026 Travere Therapeutics, Inc. (Nasdaq: TVTX) is set to present nine new data analyses, including…
Singleton Associates and Blue Cross and Blue Shield of Texas Reach Multi-Year Agreement to Maintain In-Network Radiology Access Singleton Associates, P.A. (Singleton Associates), a radiology practice affiliated with Radiology Partners,…
GeneDx to Launch Easy Order at 2026 AAP Conference to Simplify Genomic Testing for Pediatricians GeneDx, a company focused on rare disease diagnosis and improving health through genomic data, will…
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial-Scale Facility for Lead-212 Targeted Alpha Therapies Orano Med, a subsidiary of the Orano Group and a pioneer in targeted alpha therapies for…
ILiAD Biotechnologies Publishes Phase 2b SUPER Trial Results for Intranasal Pertussis Vaccine Candidate BPZE1 in The Lancet Infectious Diseases ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on…
Verastem Oncology Presents New Data Supporting Avutometinib Plus Defactinib Across Molecular Subgroups in Recurrent LGSOC Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company focused on developing new medicines for patients with…
LISTERINE® Launches Oral Care Counts Initiative to Highlight the Essential Role of Oral Health in Overall Wellbeing LISTERINE® is launching Oral Care Counts, a multiyear education and advocacy initiative designed…
AngioDynamics Supports Jacobi Hospital Study Investigating CT Pulmonary Angiography Radiomics in Pulmonary Embolism AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring blood flow within the vascular system,…
Italfarmaco and JCR Pharmaceuticals Enter Exclusive Agreement to Advance JR-141 for Hunter Syndrome in Global Markets Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE: 4552) have entered into an exclusive…
Summit Therapeutics, Daiichi Sankyo and AstraZeneca Launch Clinical Collaboration to Evaluate Ivonescimab and Datroway in Solid Tumors Summit Therapeutics Inc. (Nasdaq: SMMT) has announced a clinical trial collaboration agreement with…
Blue Matter Launches Behavioral Science Center of Excellence to Strengthen Biopharma Market Research and Decision-Making Blue Matter has announced the launch of its Behavioral Science Center of Excellence (BeSci CoE),…